EXPRESSION OF CONCERN: Beneficial Effects of Co-Ultramicronized Palmitoylethanolamide/Luteolin in a Mouse Model of Autism and in a Case Report of Autism
ReviewOther animalsHumansWith luteolin
This study tested palmitoylethanolamide together with luteolin. Its results cannot be assigned to palmitoylethanolamide alone. More combination studies.
- Design
- Review
- Subjects
- Not stated in the abstract
- Dose used in the study
- Not stated in the abstract
- Duration
- Not stated in the abstract
- What was measured
- Not applicable; this is a publisher's expression of concern notice, not a study report.
What the authors reported
The journal published an expression of concern for the 2017 paper "Beneficial Effects of Co-Ultramicronised Palmitoylethanolamide/Luteolin in a Mouse Model of Autism and in a Case Report of Autism" by Bertolino B et al (PMID 27701827). The PubMed record gives no further detail on the reasons for the concern.
Limits of this study
This is an administrative notice, not a new study. Readers of the original 2017 paper, which combined a mouse model and a single human case report, should treat its findings as under review. No conflict or funding information is stated.
Source
PubMed 39651688 · doi:10.1111/cns.70169
Entry checked against the PubMed record; the notice has no abstract on 2026-09-22. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.